FOXP3 and neoplasm: These results agree with those reported in melanoma, which indicates that FOXP3 in cancer cells modulates the expression of molecules associated with immunity, in addition to contributing to the recruitment of Treg lymphocytes, which establishes a suppressive activity that favors tumor progression [78].